Keeping Pace in Oncology

Oncology data evolves and emerges at a rapid pace leading to a proliferation of new actionable mutations, therapeutic targets, new therapies, and changes in treatment sequencing. The Keeping Pace in Oncology CME series has been developed to synthesize the latest data from clinical trials to help community oncologists keep pace with the rapid changes and best practices for integrating advances into clinical practice. Educational modules feature conversations with leading experts to explore clinical insights and perspectives on patient-centered treatment.

LikeLikedUnlike

Episodes 1-13 of 13

- Paul Paik, MD
  Peer
- Joshua K. Sabari, MD
  Peer
3
CME/CE
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC
0.25 credits
- Paul Paik, MD
  Peer
- Viola Zhu, MD
  Peer
0
CME/CE
Therapy Gaps: Identifying New Targets in the Management of NSCLC
Therapy Gaps: Identifying New Targets in the Management of NSCLC
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Ana Oaknin, MD
  Peer
1
CME/CE
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
Keeping Pace in Women’s Cancer: Clinical Considerations for Endometrial Cancer—Global Perspectives
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Nicoletta Colombo, MD
  Peer
- Christine Ghione
  Peer
2
CME/CE
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
0.25 credits
- Paul Paik, MD
  Peer
- Jyoti D. Patel, MD, FASCO
  Peer
5
CME/CE
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations
0.25 credits
- Federico Cappuzzo
  Peer
- Professor Solange Peters
  Peer
- Professor Yi-Long Wu
  Peer
4
CME/CE
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
The Latest Clinical Considerations for Non-Small Cell Lung Cancer: A Global Approach
0.25 credits
- Floor J. Backes, MD
  Peer
- Robert L. Coleman, MD, FACOG, FACS
  Peer
11
CME/CE
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
Keeping Pace in Women’s Cancers: Ovarian Cancer—From IO to PARP
0.25 credits
- Peter Schmid, FRCP, MD, PhD
  Peer
- Javier Cortes, MD, PhD
  Peer
6
CME/CE
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
Keeping Pace in Women’s Cancers: Updates in Triple-Negative Breast Cancer
0.25 credits
- Edward Chu, MD
  Peer
- Michael J. Overman, MD
  Peer
7
CME/CE
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
Keeping Pace in GI Cancer: Advances in Immunotherapy in MSI-H/dMMR Metastatic Colorectal Cancer
0.25 credits
- Scott Kopetz, MD, PhD
  Peer
- Prof Eric Van Cutsem, MD, PhD
  Peer
- Josep Tabernero, MD, PhD
  Peer
9
CME/CE
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
Optimizing Treatment Selection in BRAF V600E-Mutated Metastatic Colorectal Cancer
0.25 credits
- Richard T. Penson, MD, MRCP
  Peer
- Linda R. Duska, MD, MPH
  Peer
20
CME/CE
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
Keeping Pace in Women’s Cancer: Focus on Endometrial Carcinoma
0.25 credits
- Mark A. Socinski, MD
  Peer
- Alexander Drilon, MD
  Peer
11
CME/CE
Keeping Pace: Advances in RET Fusion-Positive NSCLC
Keeping Pace: Advances in RET Fusion-Positive NSCLC
0.25 credits
- Mark A. Socinski, MD
  Peer
- Helena Yu, MD
  Peer
9
CME/CE
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC
0.25 credits

ReachMD